Roberto Marasca, Dr

Department of Medical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Italy

NA

Poster(s):

• 1007 - XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling